Bacterial Etiology of Urinary Tract Infection and Antibiogram Profile in Children Attending Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia

Table 5

Antimicrobial susceptibility pattern for the Gram-negative bacteria isolated from urine cultures of the pediatric patients visiting Debre Tabor Comprehensive Specialized Hospital.

Bacterial isolates	Antimicrobial agents tested (n = 11)
	P	AMC no (%)	CIP no (%)	MER no (%)	AMP no (%)	CN no (%)	NIT no (%)	TET no (%)	CHL no (%)	SXT no (%)	CTR no (%)	CAZ no (%)
E. Coli (n = 19)	S	12 (63.2)	3 (15.8)	19 (100)	9 (47.4)	5 (26.3)	0 (0)	2 (10.5)	6 (31.6)	1 (5.3)	16 (84.2)	11 (57.9)
	I	0 (0)	0 (0)	0 (0)	0 (0)	2 (10.5)	0 (0)	1 (5.3)	0 (0)	0 (0)	1 (5.3)	0 (0)
	R	7 (36.8)	16 (84.2)	0 (0)	10 (52.6)	12 (63.2)	19 (100)	16 (84.2	13 (68.4)	18 (94.7)	2 (10.5)	8 (42.1)
K. pneumoniae (n = 9)	S	2 (22.2)	0 (0)	7 (77.8)	3 (33.3)	0 (0)	0 (0)	2 (22.2)	0 (0)	0 (0)	5 (55.6)	7 (77.8)
	I	0 (0)	0 (0)	0 (0)	2 (22.2)	0 (0)	0 (0)	0 (0)	4 (44.4)	0 (0)	2 (22.2)	0 (0)
	R	7 (77.8)	9 (100)	2 (22.2)	4 (44.4)	9 (100)	9 (100)	7 (77.8)	5 (55.6)	9 (100)	2 (22.2)	2 (22.2)
Citrobacter spp. (n = 4)	S	2 (50)	2 (50)	4 (100)	0 (0)	3 (75)	1 (25)	0 (0)	1 (25)	0 (0)	3 (75)	1 (25)
	I	1 (25)	0 (0)	0 (0)	0 (0)	1 (25)	1 (25)	0 (0)	0 (0)	0 (0)	0 (0)	1 (25)
	R	1 (25)	2 (50)	0 (0)	4 (100)	0 (0)	2 (50)	4 (100)	3 (75)	4 (100)	1 (25)	2 (50)
Acinetobacter spp. (n = 3)	S	—	0 (0)	3 (100)	—	0 (0)	—	—	—	0 (0)	1 (33.3)	0 (0)
	I	—	0 (0)	0 (0)	—	0 (0)	—	—	—	0 (0)	0 (0)	1 (33.3)
	R	—	3 (100)	0 (0)	—	3 (100)	—	—	—	3 (100)	2 (66.7)	2 (66.7)
P. aeruginosa (n = 7)	S	—	3 (42.9)	6 (85.7)	—	1 (14.3)	—	—	—	—	—	5 (71.4)
	I	—	2 (28.6)	0 (0)	—	2 (28.6)	—	—	—	—	—	0 (0)
	R	—	2 (28.6)	1 (14.3)	—	4 (57.1)	—	—	—	—	—	2 (28.6)
Total (%)	S	16 (38.1)	8 (19)	39 (92.9)	12 (28.6)	9 (21.4)	1 (2.4)	4 (9.5)	7 (16.7)	1 (2.4)	25 (59.5)	24 (57.1)
	I	1 (2.4)	2 (4.7)	0	2 (4.7)	5 (11.9)	1 (2.4)	1 (2.4)	4 (9.5)	0	3 (7.1)	2 (4.7)
	R	15 (35.7)	32 (76.2)	3 (7.1)	18 (42.9)	28 (66.7)	30 (71.4)	27 (64.3)	21 (50)	34 (81)	7 (16.7)	18 (42.9)

“—” denotes not applicable; P, patterns; AMC, amoxicillin-clavulanate acid (20/10 μg); AMP, ampicillin (10 μg); CTR, ceftriaxone (30 μg); CHL, chloramphenicol (30 μg); CIP, ciprofloxacin (5 μg); CN, gentamicin (10 μg); MER, meropenem (10 μg); NIT, nitrofurantoin (300 μg); TET, tetracycline (30 μg); SXT, trimethoprim-sulfamethoxazole (1.25/23.75 μg); CAZ, ceftazidime (30 μg); S, sensitive; I, intermediate; R, resistant.